HRTX
Heron Therapeutics Inc
Price:  
2.20 
USD
Volume:  
823,589.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HRTX EV/EBITDA

-163.4%
Upside

As of 2025-07-05, the EV/EBITDA ratio of Heron Therapeutics Inc (HRTX) is -76.03. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HRTX's latest enterprise value is 466.12 mil USD. HRTX's TTM EBITDA according to its financial statements is -6.13 mil USD. Dividing these 2 quantities gives us the above HRTX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.9x - 13.8x 13.2x
Forward P/E multiples 12.2x - 16.1x 13.6x
Fair Price (1.35) - (1.41) (1.39)
Upside -161.2% - -164.0% -163.4%
2.20 USD
Stock Price
(1.39) USD
Fair Price

HRTX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-03 -76.03
2025-07-02 -74.78
2025-07-01 -75.28
2025-06-30 -72.79
2025-06-27 -74.53
2025-06-26 -75.03
2025-06-25 -74.78
2025-06-24 -74.78
2025-06-23 -73.79
2025-06-20 -71.05
2025-06-18 -71.05
2025-06-17 -69.81
2025-06-16 -71.80
2025-06-13 -69.31
2025-06-12 -71.30
2025-06-11 -72.54
2025-06-10 -74.04
2025-06-09 -74.04
2025-06-06 -73.54
2025-06-05 -71.05
2025-06-04 -72.04
2025-06-03 -71.05
2025-06-02 -69.31
2025-05-30 -68.06
2025-05-29 -68.81
2025-05-28 -66.82
2025-05-27 -68.31
2025-05-23 -67.32
2025-05-22 -67.81
2025-05-21 -68.06
2025-05-20 -69.06
2025-05-19 -69.06
2025-05-16 -70.30
2025-05-15 -67.81
2025-05-14 -64.08
2025-05-13 -67.07
2025-05-12 -72.29
2025-05-09 -73.79
2025-05-08 -75.28
2025-05-07 -77.52
2025-05-06 -81.50
2025-05-05 -74.28
2025-05-02 -78.76
2025-05-01 -79.76
2025-04-30 -81.50
2025-04-29 -79.51
2025-04-28 -79.26
2025-04-25 -78.51
2025-04-24 -77.77
2025-04-23 -76.03